ATE227131T1 - Orale zusammenstellung die 5-aminosalicylsäure enthält - Google Patents

Orale zusammenstellung die 5-aminosalicylsäure enthält

Info

Publication number: ATE227131T1
Authority: AT; Austria
Prior art keywords: oral; aminosalicylic acid; ulcers; composition containing; oral composition
Prior art date: 1996-08-13

Application number

AT97918973T

Other languages

English (en)

Inventor

Thomas Buser

Original Assignee

Tillotts Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-13

Filing date

1997-08-12

Publication date

2002-11-15

1997-08-12 Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag

2002-11-15 Application granted granted Critical

2002-11-15 Publication of ATE227131T1 publication Critical patent/ATE227131T1/de

Links

KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 title abstract 3
229960004963 mesalazine Drugs 0.000 title abstract 3
208000025865 Ulcer Diseases 0.000 abstract 2
230000003902 lesion Effects 0.000 abstract 2
231100000397 ulcer Toxicity 0.000 abstract 2
RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
208000007117 Oral Ulcer Diseases 0.000 abstract 1
208000005522 Orofacial Granulomatosis Diseases 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
229940074096 monoolein Drugs 0.000 abstract 1
210000000214 mouth Anatomy 0.000 abstract 1
208000014996 oral Crohn disease Diseases 0.000 abstract 1
206010030983 oral lichen planus Diseases 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)

AT97918973T 1996-08-13 1997-08-12 Orale zusammenstellung die 5-aminosalicylsäure enthält ATE227131T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9617001.4A GB9617001D0 (en)	1996-08-13	1996-08-13	Oral composition
PCT/EP1997/004376 WO1998006387A2 (en)	1996-08-13	1997-08-12	Oral composition comprising 5-aminosalicylic acid

Publications (1)

Publication Number	Publication Date
ATE227131T1 true ATE227131T1 (de)	2002-11-15

Family

ID=10798432

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97918973T ATE227131T1 (de)	1996-08-13	1997-08-12	Orale zusammenstellung die 5-aminosalicylsäure enthält

Country Status (12)

Country	Link
US (1)	US6217897B1 (de)
EP (1)	EP0951287B1 (de)
JP (1)	JP4597273B2 (de)
AT (1)	ATE227131T1 (de)
AU (1)	AU4298597A (de)
CA (1)	CA2263070C (de)
DE (1)	DE69716947T2 (de)
DK (1)	DK0951287T3 (de)
ES (1)	ES2188933T3 (de)
GB (1)	GB9617001D0 (de)
PT (1)	PT951287E (de)
WO (1)	WO1998006387A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0001449D0 (en) *	2000-01-21	2000-03-08	Cortendo Ab	Compositions
MXPA03006699A (es) *	2001-01-26	2004-05-31	Univ Emory	Metodos de induccion de tolerancia al trasplante de organos y correccion de hemoglobinopatias.
CA2473143A1 (en) *	2002-02-08	2003-08-14	Johnson & Johnson Gmbh	Compositions containing oat straw and willowherb extract
KR100533460B1 (ko) *	2002-07-20	2005-12-08	대화제약 주식회사	난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
JP4669960B2 (ja) *	2003-06-03	2011-04-13	株式会社メドレックス	局所麻酔薬を含有する口中用または咽頭部用製剤
US20060127437A1 (en) *	2004-12-13	2006-06-15	Misty Anderson Kennedy	Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) *	2004-12-13	2007-03-15	Kennedy John P	Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) *	2004-12-13	2013-09-17	Southeastern Medical Technologies, Llc	Agents for controlling biological fluids and methods of use thereof
ITRM20050390A1 (it)	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050389A1 (it)	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
IE20070129A1 (en) *	2007-02-28	2008-12-24	Giuliani Int Ltd	Ppar-gamma agonists stimulate enteric defensin expression
UA107562C2 (uk)	2008-12-05	2015-01-26		Спосіб лікування псоріазу
EA020856B1 (ru)	2009-02-16	2015-02-27	Джулиани Интернэшнл Лимитед	Способы лечения патологических состояний, связанных с волосами
US20140030354A1 (en) *	2011-03-09	2014-01-30	Paul F. Reid	Composition and method for oral delivery of cobra venom
JP6301844B2 (ja)	2012-02-09	2018-03-28	ノグラファーマリミテッド	線維症の処置方法
EP2844242A1 (de)	2012-04-18	2015-03-11	Nogra Pharma Limited	Verfahren zur behandlung lactoseintoleranz
CN102697937A (zh) *	2012-06-28	2012-10-03	王佳丽	一种治疗口腔溃疡的药物及其制备方法
RU2540493C1 (ru) *	2013-12-10	2015-02-10	Гюзель Маратовна Акмалова	Способ местного лечения красного плоского лишая слизистой оболочки полости рта типичной формы
EP3921299B1 (de)	2019-02-08	2024-11-20	Nogra Pharma Limited	Verfahren zur herstellung von 3-(4'-aminophenyl)-2-methoxypropionsäure, sowie analoge und zwischenprodukte davon
CN113350277A (zh) *	2021-06-30	2021-09-07	广东科伦药业有限公司	一种治疗化疗口腔黏膜炎的美沙拉秦含漱液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2065980T3 (es)	1988-05-05	1995-03-01	Tillotts Pharma Ag	Uso del acido 5-aminosalicilico en el tratamiento de alteraciones dermatologicas.
DK254289D0 (da) *	1989-05-25	1989-05-25	Dumex Ltd As	Middel til behandling af svampeinfektioner
US5262164A (en)	1989-11-17	1993-11-16	The Procter & Gamble Company	Sustained release compositions for treating periodontal disease
NL9000237A (nl) *	1990-01-31	1991-08-16	Re Novative Drugs For Dermatol	Topicale farmaceutische composities voor de mondholte en vagina.
AU685262B2 (en)	1994-03-30	1998-01-15	Gs Development Ab	Use of fatty acid esters as bioadhesive substances

1996
- 1996-08-13 GB GBGB9617001.4A patent/GB9617001D0/en active Pending
1997
- 1997-08-12 CA CA002263070A patent/CA2263070C/en not_active Expired - Fee Related
- 1997-08-12 EP EP97918973A patent/EP0951287B1/de not_active Expired - Lifetime
- 1997-08-12 ES ES97918973T patent/ES2188933T3/es not_active Expired - Lifetime
- 1997-08-12 US US09/147,631 patent/US6217897B1/en not_active Expired - Fee Related
- 1997-08-12 WO PCT/EP1997/004376 patent/WO1998006387A2/en not_active Ceased
- 1997-08-12 AU AU42985/97A patent/AU4298597A/en not_active Abandoned
- 1997-08-12 JP JP50940098A patent/JP4597273B2/ja not_active Expired - Fee Related
- 1997-08-12 AT AT97918973T patent/ATE227131T1/de active
- 1997-08-12 DK DK97918973T patent/DK0951287T3/da active
- 1997-08-12 DE DE69716947T patent/DE69716947T2/de not_active Expired - Lifetime
- 1997-08-12 PT PT97918973T patent/PT951287E/pt unknown

Also Published As

Publication number	Publication date
DE69716947D1 (de)	2002-12-12
EP0951287B1 (de)	2002-11-06
GB9617001D0 (en)	1996-09-25
PT951287E (pt)	2003-03-31
JP2000516227A (ja)	2000-12-05
US6217897B1 (en)	2001-04-17
WO1998006387A3 (en)	1998-03-19
ES2188933T3 (es)	2003-07-01
CA2263070C (en)	2009-09-08
CA2263070A1 (en)	1998-02-19
AU4298597A (en)	1998-03-06
JP4597273B2 (ja)	2010-12-15
WO1998006387A2 (en)	1998-02-19
DE69716947T2 (de)	2003-07-17
DK0951287T3 (da)	2002-12-09
EP0951287A2 (de)	1999-10-27

Legal Events

Date

Code

Title

Description

2003-04-15

UEP

Publication of translation of european patent specification

Ref document number: 0951287

Country of ref document: EP

Publication	Publication Date	Title
DE69716947D1 (de)	2002-12-12	Orale zusammenstellung die 5-aminosalicylsäure enthält
RU93047799A (ru)	1996-03-20	Композиции, содержащие ретиноевые кислоты и токоферол
IL154693A (en)	2010-04-15	Use of testosterone gel to make a remedy for testosterone deficiency in women
RU93005355A (ru)	1995-09-27	Фармакологические композиции
NZ236797A (en)	1993-03-26	Topical compositions comprising ibuprofen (or s-ibuprofen) dissolved in a hydroalcoholic gel having a ph of 3.5 to 6.0 and use thereof
ATE187887T1 (de)	2000-01-15	Verzögerte freigabe matrix für arzneimittel
ATE126055T1 (de)	1995-08-15	Naproxen-formulierung zur kontrollierten absorption zur einmal täglichen anwendung.
NO923809L (no)	1993-04-02	Farmasoeytisk preparat
EP0280737A4 (de)	1988-12-12	Steroidenheilmittelzubereitung zur äusserlichen verwendung.
EP0282316A3 (de)	1990-03-07	Schicht- oder Gelwundverband
JPS57171912A (en)	1982-10-22	Cream
DE69102147D1 (de)	1994-07-07	Zusammensetzung zur lokalen Anwendung.
CA2140545A1 (en)	1994-03-03	Use of first runnings coconut fatty acid as insect-repellent
SE9403158D0 (sv)	1994-09-21	New use of prostaglandins
IT1275556B (it)	1997-08-07	Procedimento ed impianto per la disidratazione di foraggio, particolarmente per la disidratazione dell'erba medica
FI896321A7 (fi)	1990-06-30	Aktiiviainetta sisältävät mikrorakeet, jotka koostuvat pääasiassa kyllästettyjen rasvahappojen triglyseridistä, ja niiden käyttö paikallisesti sairaanhoitoalalla
NZ336600A (en)	2000-07-28	Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation
RU99117143A (ru)	2001-06-10	Применение дихлорбензилового спирта для получения лекарственного средства для местного лечения воспаления и лекарственное средство, содержащее дихлорбензиловый спирт
DE69513109D1 (de)	1999-12-09	Holunder enthaltendes Hautpflegemittel
DK0927031T3 (da)	2003-09-29	Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
ATE294568T1 (de)	2005-05-15	Zusammensetzung zur behandlung von verbrennungen
ATE97812T1 (de)	1993-12-15	Therapeutische verwendung des isopropylesterderivates von monosialogangliosiden bei erkrankungen des nervensystems, begleitet von entzuendungen.
UA885A1 (uk)	1993-12-15	Засiб для лiкуваhhя шлуhково-кишкових захворюваhь з озhаками дiареї
RU96100994A (ru)	1998-03-27	Лечебно-косметическое средство
Dutt	1940	The Treatment of Carbuncle in the Out-Patient Department